To Balance Its National Drug Control Program: Regulation
To Balance Its National Drug Control Program: Regulation
To Balance Its National Drug Control Program: Regulation
severe nausea
severe and persistent muscle spasms, including but not limited to those
associated with multiple sclerosis
Regulation
Once enacted, the law will establish under the Department of Health a Medical
Cannabis Regulatory Authority that will regulate the medical use of cannabis
in the country.
The agency will issue registered identification cards to qualified patients as
well as maintain a registry of cannabis patients' caregivers who will assist
registered qualified patients.
"This is just the first step but we are confident that by the grace of God, many
congressmen will vote yes to this."
conscientious Filipino investors to develop the full potential of local cannabinoid medicine. With
the bill, the government gets the mandate to help spur a friendly, caring and safe environment to
those who will be treated with medical cannabis.
Finally, the bill aims to create an infrastructure and dispensing system that can produce the
medicine at more affordable cost to the people.
On the other hand, there are ten medical organizations that propose the regulated importation
of oral cannabis extract and/or synthetic analogues with proven efficacy for specific symptoms
and the importation of the plant for research purposes. These will be done under current
regulations of the Dangerous Drugs Board (DDB) and the Food and Drug Administration (FDA).
The ten medical organizations plan to invoke the Compassionate Special Permit and to create a
task force composed of specialists, scientists, ethics and regulatory authorities.
Our Stand
We will continue to explore all avenues to gain immediate legal access of patients to safe,
regulated and affordable medical cannabis.
We appreciate very much the helping hand extended by the ten medical organizations. We will
encourage our patients to participate in the proposed clinical trials using imported
pharmaceutical cannabis extracts.
We implore all concerned, however, not to put our patients and their families in an
uncomfortable position where they have to choose between HB 4477 and the proposal of the
ten medical organizations.
We will continue to work for the passing of HB 4477. We uphold the interest of all Filipinos
suffering from debilitating diseases. Our bias is for the patients and their families. We support
their exclusive right to choose what is best for them. We recognize their right to participate in the
management of their own health.
In this light, we will actively promote the establishment of a multi-stakeholder Working Group
composed of doctors, hopeful patients and their families, advocates, health care policy advisers
and civil society organizations to fine tune HB 4477. We call on everyone to work hand in hand